Ignite Creation Date:
2024-05-06 @ 8:01 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06220487
Status:
RECRUITING
Last Update Posted:
2024-01-24
First Post:
2023-12-03
Brief Title:
A Single-arm Open-label Study of Olverembatinib CD3CD19 Bispecific T-cell Engager and Chidamide in Patients With Newly Diagnosed PhALL
Sponsor:
Nanfang Hospital Southern Medical University
Organization:
Nanfang Hospital Southern Medical University
Organization Data
Organization:
Nanfang Hospital Southern Medical University
Class:
OTHER
Study ID:
NFEC-2023-441
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nanfang Hospital Southern Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None